norfloxacin has been researched along with Enteric Fever in 15 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pefloxacin was well tolerated and more effective than cotrimoxazole in the treatment of typhoid fever." | 6.66 | Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults. ( Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H, 1988) |
| "Norfloxacin thus appears to be a good choice in such cases." | 5.28 | The problem of emerging chloramphenicol resistance in typhoid fever--a preliminary report. ( Agarwal, S; Guleria, JS; Madhu, SV; Talwar, V, 1991) |
| "The in vitro activities of enoxacin, lomefloxacin, norfloxacin, ofloxacin, and pefloxacin against 274 strains of Salmonella typhi isolated from suspected typhoid fever patients (137 multi-resistant strains and 137 strains sensitive to chloramphenicol, ampicillin and/or co-trimoxazole) were determined using disk diffusion and agar dilution techniques." | 3.68 | Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi. ( Hannan, A, 1992) |
| "Pefloxacin was well tolerated and more effective than cotrimoxazole in the treatment of typhoid fever." | 2.66 | Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults. ( Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H, 1988) |
| "Typhoid and paratyphoid are febrile illnesses, due to a bacterial infection, which remain common in many low- and middle-income countries." | 2.47 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). ( Bhutta, ZA; Critchley, JA; Effa, EE; Garner, P; Lassi, ZS; Olliaro, PL; Sinclair, D, 2011) |
| "The rate of recurrence and ADR in the NFX group was lower than that in the CP group." | 1.30 | [Observation of 212 cases of typhoid fever treated with FQNS]. ( Feng, S; Jiang, S; Wang, X, 1997) |
| "One hundred and seventy-eight cases of typhoid patients were studied on clinical and bacteriological aspects." | 1.30 | [Clinical and laboratory studies with typhoid fever 178 patients]. ( Ji, B; Lu, M; Ouyang, K, 1997) |
| "Various neuropsychiatric syndromes in typhoid fever were seen in nine patients of multiple drug resistant (both in vitro and in vivo) Salmonella typhi infection of a total of 270 suspected cases in the last two years." | 1.28 | Neuropsychiatric manifestations of typhoid fever. ( Ali, G; Allaqaband, GQ; Aziz, A; Hussain, A; Kamili, MA; Koul, RL; Shah, MY, 1992) |
| "Norfloxacin thus appears to be a good choice in such cases." | 1.28 | The problem of emerging chloramphenicol resistance in typhoid fever--a preliminary report. ( Agarwal, S; Guleria, JS; Madhu, SV; Talwar, V, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thaver, D | 2 |
| Zaidi, AK | 2 |
| Critchley, JA | 2 |
| Azmatullah, A | 1 |
| Madni, SA | 2 |
| Bhutta, ZA | 3 |
| Effa, EE | 1 |
| Lassi, ZS | 1 |
| Garner, P | 1 |
| Sinclair, D | 1 |
| Olliaro, PL | 1 |
| Critchley, J | 1 |
| Singh, CP | 2 |
| Singh, N | 1 |
| Brar, GK | 2 |
| Lal, G | 2 |
| Kumar, H | 1 |
| Jiang, S | 1 |
| Wang, X | 1 |
| Feng, S | 1 |
| Lu, M | 1 |
| Ji, B | 1 |
| Ouyang, K | 1 |
| Hannan, A | 1 |
| Watson, JP | 1 |
| Sing, N | 1 |
| Parsad, D | 1 |
| Ali, G | 1 |
| Kamili, MA | 1 |
| Shah, MY | 1 |
| Koul, RL | 1 |
| Aziz, A | 1 |
| Hussain, A | 1 |
| Allaqaband, GQ | 1 |
| Zhang, YY | 1 |
| Zhun, BY | 1 |
| Jiang, SC | 1 |
| Agarwal, S | 1 |
| Madhu, SV | 1 |
| Guleria, JS | 1 |
| Talwar, V | 1 |
| Velmonte, MA | 1 |
| Montalban, CS | 1 |
| Hajji, M | 1 |
| el Mdaghri, N | 1 |
| Benbachir, M | 1 |
| el Filali, KM | 1 |
| Himmich, H | 1 |
| Gotuzzo, E | 1 |
| Guerra, JG | 1 |
| Benavente, L | 1 |
| Palomino, JC | 1 |
| Carrillo, C | 1 |
| Lopera, J | 1 |
| Delgado, F | 1 |
| Nalin, DR | 1 |
| Sabbaj, J | 1 |
3 reviews available for norfloxacin and Enteric Fever
| Article | Year |
|---|---|
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Topics: Adult; Anti-Bacterial Agents; Child; Fluoroquinolones; Humans; Norfloxacin; Paratyphoid Fever; Rando | 2008 |
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Topics: Adult; Anti-Bacterial Agents; Child; Fluoroquinolones; Humans; Norfloxacin; Paratyphoid Fever; Rando | 2011 |
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Topics: Adult; Anti-Infective Agents; Child; Fluoroquinolones; Humans; Norfloxacin; Paratyphoid Fever; Rando | 2005 |
5 trials available for norfloxacin and Enteric Fever
| Article | Year |
|---|---|
Efficacy of ciprofloxacin and norfloxacin in multidrug resistant enteric fever in adults.
Topics: Adolescent; Adult; Ampicillin Resistance; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance | 1993 |
[Clinical evaluation of enoxacin].
Topics: Adult; Dysentery, Bacillary; Enoxacin; Female; Gram-Negative Bacterial Infections; Humans; Male; Mid | 1991 |
Norfloxacin in the treatment of infections caused by Salmonella typhi.
Topics: Administration, Oral; Clinical Trials as Topic; Female; Humans; Male; Norfloxacin; Typhoid Fever | 1988 |
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Topics: Adult; Drug Combinations; Female; Humans; Male; Norfloxacin; Paratyphoid Fever; Pefloxacin; Prospect | 1988 |
Use of norfloxacin to treat chronic typhoid carriers.
Topics: Adolescent; Adult; Aged; Carrier State; Clinical Trials as Topic; Double-Blind Method; Female; Human | 1988 |
7 other studies available for norfloxacin and Enteric Fever
| Article | Year |
|---|---|
[Observation of 212 cases of typhoid fever treated with FQNS].
Topics: Adult; Anti-Infective Agents; Child; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Recurrence; Typho | 1997 |
[Clinical and laboratory studies with typhoid fever 178 patients].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Female; Hepatitis; Humans; Male; Microbial Se | 1997 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquin | 1992 |
Multi-resistant typhoid fever in Nepal.
Topics: Ampicillin Resistance; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Nepal; Norflo | 1992 |
Therapy of enteric fever.
Topics: Chloramphenicol Resistance; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Humans; India; | 1992 |
Neuropsychiatric manifestations of typhoid fever.
Topics: Adolescent; Adult; Bacteremia; Drug Resistance, Microbial; Female; Humans; Male; Mental Disorders; N | 1992 |
The problem of emerging chloramphenicol resistance in typhoid fever--a preliminary report.
Topics: Chloramphenicol; Chloramphenicol Resistance; Disease Outbreaks; Humans; India; Microbial Sensitivity | 1991 |